39
Participants
Start Date
January 20, 2020
Primary Completion Date
February 27, 2022
Study Completion Date
February 27, 2022
ODACTRA 12 SQ-HDM Sublingual Tablet
Subjects are randomized to either HDM-AIT or Placebo for 24 weeks of therapy
Placebo sublingual tablet
Subjects are randomized to either HDM-AIT or Placebo for 24 weeks of therapy
Respiratory Research Unit, Copenhagen
University of Copenhagen
OTHER
ALK-Abelló A/S
INDUSTRY
Lund University
OTHER
Bispebjerg Hospital
OTHER